Certara Inc. is a life sciences software and services company focused on biosimulation and model-informed drug development. Certara provides software tools and technology-enabled services that help pharmaceutical, biotechnology, and regulatory organizations model drug behavior, analyze pharmacokinetics and pharmacodynamics, and support clinical development and regulatory submissions. Its offerings include biosimulation platforms, clinical data automation and validation software, regulatory authoring and submission tools, and market access solutions. The company serves organizations across drug discovery, preclinical research, clinical research, and post-approval activities, supporting more data-driven decision-making throughout the drug development lifecycle. Certara Inc. plays a specialized role in the healthcare market by helping customers improve development efficiency, strengthen evidence generation, and navigate complex regulatory requirements.
Website4 Radnor Corporate Center
Radnor, PA, 19087
United States
What share of all stock conversation is about CERT?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% 0 | 0% 0 |
Of the messages about CERT that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | 100% 0 | 71.35% -16.7 | ||
| Bearish | — | — | 0% 0 | 28.65% +16.7 |
Of the messages about CERT that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | 100% | 69.72% | ||
| Technical Analysis | — | — | 0% | 7.04% | ||
| Analysts | — | — | 0% | 13.38% | ||
| Controversies | — | — | 0% | 0.7% | ||
| Earnings | — | — | 0% | 6.34% | ||
| Macro | — | — | 0% | 2.82% |
Of the messages about CERT, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 0% | 14.88% | ||
| Newcomers | 100% | 100% | 100% | 85.12% |
On August 4, Certara (NASDAQ:CERT) reported second-quarter 2026 results that told two different stories at once. Software revenue climbed 4% to $48.8 million, and bookings for that segment jumped 9%, yet the company swung to a $6.1 million net loss just a year after posting a small profit. Layered on top of a completed divestiture, […]
Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.
Investors talking about CERT also mention
| # | Name | Attention |
|---|---|---|
| 1 | Schrödinger, Inc.SDGR | 0%-0.01 |
| 2 | AbCellera Biologics Inc.ABCL | 0.24%-0.06 |
| 3 | ICU Medical, Inc.ICUI | 0%0 |
| 4 | CONMED CorporationCNMD | 0%new |
| 5 | PubMatic Inc. Class A Common StockPUBM | 0%0 |
| 6 | EXAI - Exscientia plc | —— |
| 7 | Evolent Health IncEVH | 0%0 |
| 8 | Rhythm Pharmaceuticals, Inc.RYTM | 0%0 |
| 9 | Integra LifeSciences Holdings CorporationIART | 0%0 |
| 10 | IDEAYA Biosciences Inc.IDYA | 0%-0.01 |